Skip to main content
Equibles
LGND logo

LGND · Ligand Pharmaceuticals Inc · Analyst Estimates

Track LGND — free

Use LGND with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LGND.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$272.65 -8.00 (-2.85%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.59B
Shares
19.94M

Analyst Estimates

Compare analyst forecasts for Ligand Pharmaceuticals Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Source collection is delayed; the retained verified snapshot may not include newer publications.

Consensus not yet available

Source collection is delayed; the retained verified snapshot may not include newer publications.

Key facts CIK 886163 CUSIP 53220K504 13F (30d) 17 filings 16 filers Visit website Investor relations